AR080255A1 - Tratamiento de afecciones alergicas dermatologicas. composicion farmaceutica - Google Patents

Tratamiento de afecciones alergicas dermatologicas. composicion farmaceutica

Info

Publication number
AR080255A1
AR080255A1 ARP110100550A ARP110100550A AR080255A1 AR 080255 A1 AR080255 A1 AR 080255A1 AR P110100550 A ARP110100550 A AR P110100550A AR P110100550 A ARP110100550 A AR P110100550A AR 080255 A1 AR080255 A1 AR 080255A1
Authority
AR
Argentina
Prior art keywords
treatment
affections
pharmaceutical composition
dermatological
dermatological allergy
Prior art date
Application number
ARP110100550A
Other languages
English (en)
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of AR080255A1 publication Critical patent/AR080255A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/14Drugs for dermatological disorders for baldness or alopecia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Se describe un tratamiento para una afeccion alérgica dermatologica, que usa un compuesto como [4-(5-aminometil-2-fluorofenil)piperidin-1-il][7-fluoro-1-(2-metoxietil)-4-trifluorometoxi-1H-indol-3-il]metanona. Reivindicacion 1: Un método para tratar una afeccion alérgica dermatologica, que comprende: administrar a un paciente que lo necesita una cantidad eficaz de un compuesto de la formula 1 o uno de sus correspondientes N-oxidos, profármacos, sales farmacéuticamente aceptables o solvatos.
ARP110100550A 2010-02-24 2011-02-23 Tratamiento de afecciones alergicas dermatologicas. composicion farmaceutica AR080255A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30765010P 2010-02-24 2010-02-24
FR1060021 2010-12-02

Publications (1)

Publication Number Publication Date
AR080255A1 true AR080255A1 (es) 2012-03-21

Family

ID=43901272

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP110100550A AR080255A1 (es) 2010-02-24 2011-02-23 Tratamiento de afecciones alergicas dermatologicas. composicion farmaceutica

Country Status (15)

Country Link
US (1) US20120309790A1 (es)
EP (1) EP2538942A1 (es)
JP (1) JP2013520506A (es)
KR (1) KR20130009769A (es)
CN (1) CN102858336A (es)
AR (1) AR080255A1 (es)
AU (1) AU2011220909A1 (es)
BR (1) BR112012020965A2 (es)
CA (1) CA2790946A1 (es)
MX (1) MX2012009523A (es)
RU (1) RU2521357C2 (es)
SG (1) SG183342A1 (es)
TW (1) TW201141478A (es)
UY (1) UY33242A (es)
WO (1) WO2011106334A1 (es)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002515891A (ja) * 1997-12-19 2002-05-28 スミスクライン・ビーチャム・コーポレイション 新規なピペリジン含有化合物
GB0012362D0 (en) * 2000-05-22 2000-07-12 Aventis Pharma Ltd Chemical compounds
DOP2005000039A (es) * 2004-03-26 2005-10-31 Aventis Pharma Inc Hidrocloruro de [4-(5-aminometil-2-fluoro-fenil)- piperidin-1-il]-(4-bomo-3-metil-5-propoxi-tiofen-2-il)-metanona como un inhibidor de la triptasa de mastocitos
BRPI0916920A2 (pt) * 2008-08-22 2015-11-24 Sanofi Aventis 4-(5-aminometil-2-fluoro-fenil)-piperidin-1-il]-[7-fluoro-1-(2-metóxi-etil)-4-trifluorometóxi-1h-indol-3-il]-metanona como inibidor de triptase de mastócito, seu uso e método de preparação, bem como forma cristalina

Also Published As

Publication number Publication date
EP2538942A1 (en) 2013-01-02
CN102858336A (zh) 2013-01-02
WO2011106334A1 (en) 2011-09-01
RU2012140438A (ru) 2014-03-27
SG183342A1 (en) 2012-09-27
RU2521357C2 (ru) 2014-06-27
CA2790946A1 (en) 2011-09-01
MX2012009523A (es) 2012-08-31
AU2011220909A1 (en) 2012-09-13
UY33242A (es) 2011-09-30
JP2013520506A (ja) 2013-06-06
KR20130009769A (ko) 2013-01-23
BR112012020965A2 (pt) 2016-05-03
US20120309790A1 (en) 2012-12-06
TW201141478A (en) 2011-12-01

Similar Documents

Publication Publication Date Title
CY1119490T1 (el) Παραγωγα πυραζολοπυρρολιδινης και η χρηση τους στην θεραπεια νοσηματων
BR112015003188A2 (pt) Composto, composição farmacêutica, uso do composto e método para tratar uma doença ou condição mediada por rorgammat em um paciente
EA201290184A1 (ru) Бензодиазепиновый ингибитор бромодомена
BR112012007747A2 (pt) Compostos heterocíclicos úteis como inibidores de pdk1, sua composição farmacêutica e seus usos
PE20121617A1 (es) Derivados de oxazina como inhibidores de bace
EA201201658A1 (ru) Производные пиперидина и их применение для лечения метаболических нарушений
CR20130432A (es) 1,3-oxazinas como inhibidores de la bace1 y/o de la bace2
NZ708593A (en) Novel pyrazole derivative
EA201592256A1 (ru) Производные имидазопирролидинона и их применение при лечении заболеваний
BR112014004504A2 (pt) "composto como inibidor de c-kit cinase, seu uso, composição farmacêutica, e medicamento para o tratamento de uma doença mediada por uma cinase"
BR112014032734A2 (pt) derivados de pirrolidina e seu uso como moduladores da série de reação de complemento
NZ706635A (en) Inhibitors of histone demethylases
SV2009003299A (es) Derivados de dihidropiridina de utilidad como inhibidores de la proteina quinasa
EA201100358A1 (ru) Дабигатран для чрескожной хирургической катетеризации сердца
BRPI1014902A2 (pt) composto antagonista de p2x7r, sua composição e seus usos
TN2015000084A1 (fr) Pyridinones bicycliques nouvelles
WO2010093727A8 (en) Quinazolinones as prolyl hydroxylase inhibitors
MX2011009847A (es) Agentes antihelminticos y su uso.
EA201691058A1 (ru) Производные пирролопирролона и их применение для лечения заболеваний
BR112015029401A8 (pt) derivados de pirazolo-pirrolidin-4-ona, seus usos, e composição e combinação farmacêuticas
UA113538C2 (xx) Фторметил-5,6-дигідро-4h-$1,3]оксазини
BR112015019412A2 (pt) inibidores de bace1
EA201390984A1 (ru) Гетероциклические соединения, подходящие для лечения дислипидемии
MX2012013879A (es) Derivados de hidroxipiridona, composiciones farmceuticas de los mismos y su uso terapeutico para tratar enfermedades proliferativas.
BR112013010136A2 (pt) vacina, composição terapêutica e métodos para o tratamento ou inibição de gliblastoma

Legal Events

Date Code Title Description
FB Suspension of granting procedure